Literature DB >> 22553432

The isolation rate of Escherichia coli 0157:H7 in Toronto and surrounding communities.

A E Simor1, C Watt, D E Low.   

Abstract

Verocytotoxin-producing strains of Escherichia coli, most often serotype 0157:H7, have been associated with both sporadic and epidemic diarrheal disease in Canada. In order to determine the isolation rate of E coli 0157:H7 in outpatients with diarrhea, all stool specimens submitted for culture to Med-Chem Laboratories in Metropolitan Toronto between June 1988 and September 1989 were cultured on MacConkey-Sorbitol agar in addition to standard enteric media. A total of 46 (0.3%) of 16,125 stool specimens yielded E coli 0157:H7 or verotoxin-producing E coli 0157:H(-). These isolates came from 31 patients with diarrhea; only 16 (52%) had a history of hemorrhagic colitis and one patient developed hemolytic uremic syndrome. Although MacConkey-Sorbitol agar was useful as a differential medium for detecting E coli 0157:H7, 14.5% of all specimens yielded nonsorbitol-fermenting isolates. It is not certain whether the routine use of MacConkey-Sorbitol agar is justified when isolation rates of E coli 0157:117 are very low.

Entities:  

Keywords:  Escherichia coli 0157:H7; Hemorrhagic colitis

Year:  1990        PMID: 22553432      PMCID: PMC3327950          DOI: 10.1155/1990/583209

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  22 in total

1.  Improved biochemical screening procedure for small clinical laboratories for vero (Shiga-like)-toxin-producing strains of Escherichia coli O157:H7.

Authors:  D J Haldane; M A Damm; J D Anderson
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

2.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7.

Authors:  R S Remis; K L MacDonald; L W Riley; N D Puhr; J G Wells; B R Davis; P A Blake; M L Cohen
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

3.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

4.  Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings.

Authors:  C A Ryan; R V Tauxe; G W Hosek; J G Wells; P A Stoesz; H W McFadden; P W Smith; G F Wright; P A Blake
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

5.  Sporadic occurrence of hemorrhagic colitis associated with Escherichia coli O157:H7 in Newfoundland.

Authors:  S Ratnam; S B March
Journal:  CMAJ       Date:  1986-01-01       Impact factor: 8.262

6.  Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis.

Authors:  S B March; S Ratnam
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

7.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

Review 8.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  1 in total

Review 1.  Estimating the burden of foodborne diseases in Japan.

Authors:  Yuko Kumagai; Stuart Gilmour; Erika Ota; Yoshika Momose; Toshiro Onishi; Ver Luanni Feliciano Bilano; Fumiko Kasuga; Tsutomu Sekizaki; Kenji Shibuya
Journal:  Bull World Health Organ       Date:  2015-06-01       Impact factor: 9.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.